These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14644329)

  • 41. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer.
    Blasiak J; Arabski M; Krupa R; Wozniak K; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Zadrozny M
    Mutat Res; 2004 Oct; 554(1-2):139-48. PubMed ID: 15450412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chromosomal aberrations, sister chromatid exchanges and micronuclei induced in human lymphocytes by sodium bisulfite (sulfur dioxide)].
    Meng Z; Zhang L
    Yi Chuan Xue Bao; 1994; 21(1):1-6. PubMed ID: 8003345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relationship of clinicopathological features and chemotherapeutic outcomes in women with BRCA1 and BRCA2 mutation-negative familial breast cancer].
    Zhang J; Sun J; Ouyang T; Li JF; Wang TF; Fan ZQ; Fan T; Lin BY; Xie YT
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):185-9. PubMed ID: 26988823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genotoxic effects of chemicals in the single cell gel (SCG) test with human blood cells in relation to the induction of sister-chromatid exchanges (SCE).
    Hartmann A; Speit G
    Mutat Res; 1995 Jan; 346(1):49-56. PubMed ID: 7530329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of BRCA1 and BRCA2 mutations in southern Iranian Breast cancer patients.
    Fattahi MJ; Mojtahedi Z; Karimaghaee N; Talei AR; Banani SJ; Ghaderi A
    Arch Iran Med; 2009 Nov; 12(6):584-7. PubMed ID: 19877752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytogenetic effects of permethrin in cultured human lymphocytes.
    Barrueco C; Herrera A; Caballo C; de la Peña E
    Mutagenesis; 1992 Nov; 7(6):433-7. PubMed ID: 1474919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
    Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
    J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spontaneous and mutagen induced sister chromatid exchange in multiple sclerosis.
    Vijayalaxmi ; Newton MS; Steel CM; Evans HJ; Pentland B
    J Med Genet; 1983 Oct; 20(5):372-6. PubMed ID: 6417337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
    Lakhani SR; Gusterson BA; Jacquemier J; Sloane JP; Anderson TJ; van de Vijver MJ; Venter D; Freeman A; Antoniou A; McGuffog L; Smyth E; Steel CM; Haites N; Scott RJ; Goldgar D; Neuhausen S; Daly PA; Ormiston W; McManus R; Scherneck S; Ponder BA; Futreal PA; Peto J; Stoppa-Lyonnet D; Bignon YJ; Stratton MR
    Clin Cancer Res; 2000 Mar; 6(3):782-9. PubMed ID: 10741697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutagenicity of inhalation anaesthetics studied by the sister chromatid exchange test in lymphocytes of patients and operating room personnel.
    Husum B
    Dan Med Bull; 1987 Jun; 34(3):159-70. PubMed ID: 3297512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
    Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V
    J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations.
    Gambino G; Tancredi M; Falaschi E; Aretini P; Caligo MA
    Int J Mol Med; 2015 Apr; 35(4):950-6. PubMed ID: 25683334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells.
    Singh B; Gupta RS
    Cancer Res; 1983 Feb; 43(2):577-84. PubMed ID: 6848181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
    Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
    Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxic and genotoxic effects of extracellular generated singlet oxygen in human lymphocytes in vitro.
    Decuyper-Debergh D; Piette J; Laurent C; van de Vorst A
    Mutat Res; 1989; 225(1-2):11-4. PubMed ID: 2913488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro induction of chromosome damage by sulphasalazine in human lymphocytes.
    Mackay JM; Fox DP; Brunt PW; Hawksworth GM; Brown JE
    Mutat Res; 1989 Jan; 222(1):27-36. PubMed ID: 2563144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.